Presentation: 2020 Skoll World Forum
BVGH President & CEO, Jennifer Dent, and AAI Partner, Dr. Faruk Mohammed, discuss the steps taken to kick off the pilot drug access program in Nigeria and plans to roll the program out in other countries.
Watch here.

 

Report: 2019 AAI Annual Report 
In a little over two years, BVGH is already impacting the African cancer landscape. This report describes how AAI is disrupting the cancer crisis in Africa through its sustainable approach and network of partners.
Read here.

 

Report: BVGH Post-AORTIC 2019 Report 
AAI partners and global health change-makers engaged in workshops focused
on expanding the AAI cancer drug access program across six African countries
and operatonalizing AC³T.
Read here.

 

Blog: Disrupting the Emerging Cancer Crisis in Africa
Through partnerships and collaboration, AAI is mobilizing resources to aid African health systems to meet growing needs and cure more patients, despite the challenges posed by the increasing burden of cancer.
Read here.

 

Lab technician analyzing slides in Dakar, Senegal.

Blog: Global Cancer Research Investments Are Not Reaching Africa – How the African Access Initiative Is Changing the Trend.
BVGH analyses have revealed comparatively limited investment in cancer research at African organizations, which likely contributes to Africa’s substantial cancer disparities.
Read here.

 

Jennifer Dent ecancer Interview

ecancer Interview at the Global Health Catalyst Summit
Jennifer Dent sits down with ecancer at the 2019 Global Health Catalyst Summit to discuss how AAI is making inroads in AAI partner countries.
Watch here.

 

 

BIO International Convention 2019

Podcast: Buzz at BIO with Jennifer Dent
Jennifer Dent discussed the African Access Initiative on a new podcast series at the 2019 BIO International Convention.
Listen here.

 

 
Jennifer e-Cancer Interview 1

ecancer Interview at AACR
Jennifer Dent speaks to ecancer at the 2019 American Association for Cancer Research (AACR) meeting about how AAI is working to improve patient outcomes in Africa.
Watch here.

 

 

Article: “Shifting Africa’s Cancer Narrative from Despair to Hope”
The Biden Cancer Initiative’s blog — Pulse on Progress — featured an article on how BVGH’s African Access Initiative is working to reverse cancer morality patterns on the African continent.
Read here.

 

 

Blog: “We’ve reached an important milestone in addressing cancer in the U.S. – but success should not end there.”
We must take the lessons and strategies learned battling cancer in the U.S. and apply them on a larger scale. Global cancer trends are imbalanced. It is time for us to share our successes and create change.
Read more.

 

AC3T Group AAI

STAT News Article: “Patients of African descent are being denied the benefits of cancer breakthroughs. We’re changing that.”
Death rates from cancer are falling and access to potentially lifesaving treatments is increasing — except among Africans and Americans of African descent. This gap must be closed.
Read more.

 

BVGH’s African Access Initiative featured at the Biden Cancer Summit
BVGH was featured at the Biden Cancer Summit, hosted by Vice President Joe Biden and Dr. Jill Biden, for its commitment to addressing Africa’s long under-recognized cancer epidemic through the African Access Initiative.
Read more.

 

Video: BVGH presents AAI at Biden Cancer Summit
BVGH has launched the African Access Initiative in partnership with leading pharmaceutical companies, Pfizer and Takeda Pharmaceuticals, and is also working with five African ministries of health including Nigeria, Kenya, Côte d’Ivoire, Cameroon, and Rwanda.
Watch here.

 

Press Release: “Nigerian Federal Ministry of Health to Launch Pilot Cancer Drug Access Program with BVGH”
“Collaborating with BVGH and leading academic and industry partners, including Memorial Sloan Kettering Cancer Center, Pfizer, and Takeda, is critical for saving Nigerian cancer patients’ lives,” said Nigeria’s Honorable Minister of Health, Professor Isaac Adewole
Read more.

 
 
 
 

WIPO Re:Search Communications

Media Contact
Email:
 info@bvgh.org
Tel: +1 206-880-7778 ext. 104
View Archive

2020 BVGH Partnership Hub Mid-Year Report 
During the COVID-19 pandemic, WIPO Re:Search is more important than ever in the fight against NTDs, malaria, and tuberculosis. Read more about our partnerships and progress in the 2020 BVGH Partnership Hub Mid-Year Report.
Read more.
 
 
 

WIPO Re:Search has come a long way in the eight years since our launch and our commitment to the health of underserved communities has never
wavered.  Read more about our partnerships and progress in the 2019 BVGH Partnership Hub Annual Report.
Read more.

 

In this publication, BVGH brings to life the WIPO Re:Search portfolio of 155 R&D collaborations focused on improving the prevention, diagnosis, and treatment of some of the world’s most-devastating diseases. The stories show how global cross-sector collaborations are driving R&D for neglected infectious diseases.
Read more.

WIPO Re:Search Advancing Product Development 2019

WIPO Re:Search: Advancing Product Development for Neglected Infectious Diseases through Global Public-Private Partnerships
This publication highlights seven exciting drug development collaborations that are advancing solutions to some of the world’s most pernicious diseases. Each featured collaboration has achieved key R&D milestones and has been advanced and de-risked through WIPO Re:Search.
Read more.

TropMed Special Edition Book – Prospects for Schistosomiasis Elimination
The Journal of Tropical Medicine and Infectious Disease has published their special edition on schistosomiasis, featuring a BVGH peer-reviewed publication: “WIPO Re:Search—A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis.”
Read more.

 

2019 BVGH Partnership Hub Mid-Year Report 
BVGH established 14 new collaborations in the first half of 2019, spanning 22 companies and academic/non-profit organizations, 11 countries – 6 of which are disease-endemic – and 7 diseases.
Read more.

 

microscope

TropMed Article: “WIPO Re:Search – Catalyzing Public-Private Partnerships to Accelerate Tropical Disease Drug Discovery and Development”
Through case studies, this article illustrates how WIPO Re:Search empowers high-quality tropical disease drug discovery researchers to leapfrog their R&D programs by accessing pharmaceutical industry resources.
Read more.

2018 WIPO Re:Search Annual Report
Since the Consortium’s launch in 2011, WIPO Re:Search has grown to 140 organizations across 40 countries and boasts a portfolio of 140 R&D collaborations focused on improving the prevention, diagnosis, and treatment of NTDs, malaria, and TB.
Read more.

 

TropMed Article: “WIPO Re:Search – A Platform for Product-Centered Cross-Sector Partnerships for the Elimination of Schistosomiasis”
Using WIPO Re:Search as an example, this article highlights the opportunities for the public-private partnership model to play a key role in the elimination of schistosomiasis.
Read more.

 

Book Chapter: “Creating, Managing, and Advancing Collaborations: The Road to Successful Partnerships”
BVGH authored chapter in “The Cambridge Handbook of Private-Public Partnerships, Intellectual Property Governance, and Sustainable Development. The full open-access book can be found on Seattle University’s Digital Commons here.
Read more.

AAI beakers

Access to Medicines Foundation Article: “How to accelerate pharmaceutical R&D – A new framework for sharing IP with global health researchers”
In collaboration with BVGH, the Access to Medicine Foundation has now developed a new framework for evaluating industry IP-sharing agreements for R&D. The framework will be used for the first time as part of the 2018 Access to Medicine Index analysis.
Read more.

MedChemNet Interview with BVGH
BVGH’s own Dr. Joseph Hargan Calvopiña sits down with MedChemNet to discuss how BVGH and WIPO Re:Search are accelerating research and development for neglected tropical diseases (NTDs), malaria, and TB.
Watch here.